DUBAI, UAE / ACCESSWIRE / November 25, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), operating as M2Bio Sciences, is a pioneering biotechnology company dedicated to advancing health and wellness through innovative science-driven solutions. Specialising in researching, developing, and commercialising cutting-edge products in nutrition, health, and sustainability.
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 22, 2024 / The Institute of Biomedical Research Corp. (OTC PINK:MRES), a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions, is pleased to announce the following updates with its M2Bio Food and Beverage division: M2Bio Food and Beverage, known for its premium, healthy, and sustainably sourced products, is taking a significant step forward by announcing a strategic shift in its product lineup. After several successful years of exploring CBD-infused food products, the company has decided to discontinue this line and refocus efforts on expanding its core offerings.
| Biotechnology Industry | Healthcare Sector | Dr. Drasko D. Pekovic CEO | OTC PINK Exchange | US45781A1079 ISIN |
| ME Country | - Employees | - Last Dividend | 28 Apr 2014 Last Split | - IPO Date |
The Institute of Biomedical Research Corp., established in 2010, is at the forefront of delivering cutting-edge biomedical research and analytical services both locally in Montenegro and on a global scale. It specializes in a broad range of areas including the regulatory control of industrial activities and products, scientific monitoring of the living environment, and the development of new diagnostic methods and experimental medical treatments. The company not only focuses on the research and development of biomedical products and technologies but also on their regulatory evaluation and certification. Additionally, its efforts extend to fundamental scientific research and the advancement of knowledge in the biomedical and environmental fields. With a commitment to quality and innovation, the Institute of Biomedical Research Corp. operates from its headquarters in Podgorica, Montenegro, and maintains a representative office in Montreal, Canada, facilitating its international outreach and collaboration.